Please click on the fact sheets below to learn about key NCATS activities.
Resources for Researchers
The Assay Guidance Manual is a free, best-practices online resource devoted to the successful development of robust, early-stage drug discovery assays.
The goal of the NCATS Chemical Genomics Branch is to explore new technological and operational paradigms, ranging from new strategies for drug discovery and testing to improving the use of stem cells in research.
The CTSA Program supports a national network of medical research institutions that work together to improve the translational research process to get more treatments to all people more quickly.
NCATS uses state-of-the-art resources and core technologies to enable the ongoing operation of all translational research activities happening at the Center.
The goal of the Early Translational Branch is to uncover new small molecule therapeutics and advance the process of therapeutic development through a model of collaborative research.
The National COVID Cohort Collaborative (N3C) maintains one of the largest collections of secure and deidentified clinical data in the United States for COVID-19 research.
The OpenData Portal offers real-time information about how individual SARS-CoV-2 variants may respond to known therapeutics. It also focuses on NCATS’ broader drug repurposing findings and other pandemic threats.
The CTSA Program diversity and re-entry research supplements opportunities promote diversity in health-related research and re-entry into biomedical and behavioral research careers.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs engage U.S. small businesses and research organizations in research and development that has the potential for commercialization and public benefit.
The goal of the Therapeutic Development Branch is to help close the gap between basic research and preclinical testing of drugs as well as cell-based and gene therapies.
Resources for the Public
NCATS is speeding the translation of scientific discoveries into health solutions. The Center supports a range of initiatives to achieve a future that offers more treatments for all people more quickly.
CTSA Program hubs work hand in hand with community leaders to build strong relationships, understand community needs and improve community health.
The budget for NCATS is based on the fiscal year appropriation provided by Congress and the U.S. President. The Congressional Justification provides Congress detailed estimates and justifications for research.
A study led by NCATS estimates the direct medical costs of rare diseases and the lengthy journey some people with rare diseases travel to an accurate diagnosis.
NCATS supports a range of innovative approaches for understanding and treating rare diseases, which affect about 30 million people in this country.
Copyright and Reuse of Graphics
The NCATS website uses a mix of copyrighted and copyright-free graphics (including illustrations and photos). If you want to reuse a graphic, please follow these guidelines:
- Copyrighted graphics will usually be credited to individuals or organizations. Permission to reuse these must be negotiated directly with the creators, and not NCATS.
- Graphics explicitly credited to NCATS are copyright-free and may be used without our permission. Please credit the National Center for Advancing Translational Sciences as the source.
If you are not sure who created a graphic or have other questions about reusing a graphic on the NCATS website, email NCATS at email@example.com. Please include the URL and file name in your email.